Sarcoidosis News Home | Sarcoidosis News
网页The Foundation for Sarcoidosis Research (FSR), a nonprofit dedicated to finding new treatments and improving care for people with sarcoidosis, has nominated 14 new members to its scientific advisory board (SAB), with an aim of further enhancing research and patient care. The FSR SAB includes world-renowned researchers….
Sarcoidosis immune biomarkers, possible targeted treatments …
网页21 小时之前 · A genetic analysis of granulomas from sarcoidosis patients showed high levels of CXCR4, an immune-related gene, but its expression was minimal in people with psoriasis or healthy, unaffected skin. CXCR4, the protein produced by this gene, is critical for the movement of immune cells, including innate lymphoid cells, throughout the body. Using a ...
Approved Treatments for Sarcoidosis – Sarcoidosis News
网页Pentoxifylline. Pentoxifylline is a treatment approved to improve blood flow that also can be used to treat sarcoidosis. In addition to improving blood flow, pentoxifylline inhibits the synthesis of TNF-alpha. In sarcoidosis, the immune system can be overactivated. By decreasing TNF-alpha signaling, pentoxifylline reduces the immune response.
News Archives - Sarcoidosis News
网页High blood calcium levels, or hypercalcemia, may in rare cases be a symptom of sarcoidosis, according to a case report from Morocco. Steroid medications helped ease the symptom for a man with severe hypercalcemia as a main complication of sarcoidosis of the lungs, or pulmonary sarcoidosis, according to…. …
What Is Sarcoidosis? – Sarcoidosis News
网页2020年1月27日 · Sarcoidosis is a disease marked by an over-active immune system that leads to the formation of small clumps of inflammatory cells called granulomas in different tissues and organs, affecting how well they work. Over time, granulomas can become calcified or bone-like, and cause permanent damage. Because it can affect any organ, or multiple organs at the same time, sarcoidosis takes on different ...
Chronic Severe Pain Defines Lives of Sarcoidosis Patients, Survey...
网页2017年12月21日 · A large proportion of sarcoidosis patients live with severe chronic pain despite the heavy use of painkillers, including opioids, a recent survey found. In addition, pain considerably impacts their walking ability, sleep, and enjoyment of life. Based on the survey results, researchers argue that the nerve damage that causes pain in sarcoidosis ...
Sarcoidosis and Surgery – Sarcoidosis News
网页Sarcoidosis is an inflammatory condition where the immune system mistakenly attacks the body’s own tissues. Immune cell clusters known as granulomas accumulate in organs and tissues. Most cases are short-term or mild, but long-term chronic cases can cause serious organ damage. Because sarcoidosis often responds to treatment or may resolve without treatment, surgery is rare.
COVID-19 and Sarcoidosis – Sarcoidosis News
网页As the COVID-19 pandemic continues, Sarcoidosis News strives to cover various aspects of the virus and its impact on the patient community. Click the “Learn More” button for more information on COVID-19, including how it affects sarcoidosis patients. Scroll down to see some of our recent news stories and columns related to the pandemic.
Rare Case of Spinal Sarcoidosis Provides Guidelines for Management
网页2019年7月29日 · Now, researchers from Sapienza University of Rome described a rare case of neurosarcoidosis affecting the spine. Neurosarcoidosis occurs in about 5–15% of the cases, where granulomas develop in the nervous system.. Spinal sarcoidosis is rare and can involve either cells within the spinal cord (intramedullary), the thick membrane that covers the spinal cord (intradural extramedullary), or the ...
Sarcoidosis return after transplant, immune suppression risks seen
网页2024年7月9日 · Such treatment is a delicate balance, as immune suppression must be enough to prevent sarcoidosis from recurring, but an overly suppressed immune system can lead to life-threatening infections. More study, the scientists noted, is needed to understand whether whole-body imaging for sarcoidosis prior to …
跳至内容